文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

p53 DNA 结合域与其 N 端延伸的相互作用调节 p53 四聚体的稳定性。

Interaction of the p53 DNA-binding domain with its n-terminal extension modulates the stability of the p53 tetramer.

机构信息

MRC Laboratory of Molecular Biology, Cambridge, UK.

出版信息

J Mol Biol. 2011 Jun 10;409(3):358-68. doi: 10.1016/j.jmb.2011.03.047. Epub 2011 Mar 30.


DOI:10.1016/j.jmb.2011.03.047
PMID:21457718
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3176915/
Abstract

The tetrameric tumor suppressor p53 plays a pivotal role in the control of the cell cycle and provides a paradigm for an emerging class of oligomeric, multidomain proteins with structured and intrinsically disordered regions. Many of its biophysical and functional properties have been extrapolated from truncated variants, yet the exact structural and functional role of certain segments of the protein is unclear. We found from NMR and X-ray crystallography that the DNA-binding domain (DBD) of human p53, usually defined as residues 94-292, extends beyond these domain boundaries. Trp91, in the hinge region between the disordered proline-rich N-terminal domain and the DBD, folds back onto the latter and has a cation-π interaction with Arg174. These additional interactions increase the melting temperature of the DBD by up to 2 °C and inhibit aggregation of the p53 tetramer. They also modulate the dissociation of the p53 tetramer. The absence of the Trp91/Arg174 packing presumably allows nonnative DBD-DBD interactions that both nucleate aggregation and stabilize the interface. These data have important implications for studies of multidomain proteins in general, highlighting the fact that weak ordered-disordered domain interactions can modulate the properties of proteins of complex structure.

摘要

四聚体肿瘤抑制因子 p53 在细胞周期的控制中起着关键作用,并为新兴的寡聚、多结构域蛋白类提供了范例,这些蛋白具有结构和固有无序区域。其许多生物物理和功能特性都是从截短变体推断出来的,但该蛋白的某些片段的确切结构和功能作用尚不清楚。我们通过 NMR 和 X 射线晶体学发现,人 p53 的 DNA 结合域(DBD)通常定义为残基 94-292,超出了这些结构域的边界。位于无序脯氨酸丰富的 N 端结构域和 DBD 之间的铰链区域的色氨酸 91 回折到后者上,并与精氨酸 174 形成阳离子-π 相互作用。这些额外的相互作用将 DBD 的熔点提高了 2°C,抑制了 p53 四聚体的聚集。它们还调节 p53 四聚体的解离。Trp91/Arg174 包装的缺失可能允许非天然 DBD-DBD 相互作用,这些相互作用既能引发聚集,又能稳定界面。这些数据对一般的多结构域蛋白研究具有重要意义,突出了一个事实,即弱的有序-无序结构域相互作用可以调节复杂结构蛋白的性质。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0f/3176915/edfd463a10ee/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0f/3176915/b764dd4bf4be/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0f/3176915/4d3989fb078a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0f/3176915/790f6ba0e18b/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0f/3176915/8d75ed2b848b/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0f/3176915/ddf7993002da/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0f/3176915/0df592b5ed81/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0f/3176915/edfd463a10ee/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0f/3176915/b764dd4bf4be/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0f/3176915/4d3989fb078a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0f/3176915/790f6ba0e18b/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0f/3176915/8d75ed2b848b/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0f/3176915/ddf7993002da/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0f/3176915/0df592b5ed81/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0f/3176915/edfd463a10ee/gr6.jpg

相似文献

[1]
Interaction of the p53 DNA-binding domain with its n-terminal extension modulates the stability of the p53 tetramer.

J Mol Biol. 2011-3-30

[2]
Folding of tetrameric p53: oligomerization and tumorigenic mutations induce misfolding and loss of function.

J Mol Biol. 2009-11-11

[3]
Long-range regulation of p53 DNA binding by its intrinsically disordered N-terminal transactivation domain.

Proc Natl Acad Sci U S A. 2018-11-12

[4]
A phosphorylation-dependent switch in the disordered p53 transactivation domain regulates DNA binding.

Proc Natl Acad Sci U S A. 2021-1-5

[5]
The p53 tetramer shows an induced-fit interaction of the C-terminal domain with the DNA-binding domain.

Oncogene. 2016-6-23

[6]
The transient manifold structure of the p53 extreme C-terminal domain: insight into disorder, recognition, and binding promiscuity by molecular dynamics simulations.

Phys Chem Chem Phys. 2017-8-16

[7]
Rational design using sequence information only produces a peptide that binds to the intrinsically disordered region of p53.

Sci Rep. 2019-6-28

[8]
The p73 DNA binding domain displays enhanced stability relative to its homologue, the tumor suppressor p53, and exhibits cooperative DNA binding.

Biochemistry. 2008-3-11

[9]
Alanine and proline content modulate global sensitivity to discrete perturbations in disordered proteins.

Proteins. 2014-12

[10]
Phosphorylation Regulates the Bound Structure of an Intrinsically Disordered Protein: The p53-TAZ2 Case.

PLoS One. 2016-1-7

引用本文的文献

[1]
Pathogenic Proteins Through the Lens of NMR Spectroscopy: Structural and Functional Insights into Disease.

Cell Biochem Biophys. 2025-8-13

[2]
DARPin-induced reactivation of p53 in HPV-positive cells.

Nat Struct Mol Biol. 2025-5

[3]
Dominant-negative mutations potentiated by the HSF1-regulated proteostasis network.

bioRxiv. 2024-11-3

[4]
Covalent Modification of p53 by ()-1-(4-Methylpiperazin-1-yl)-3-(5-nitrofuran-2-yl)prop-2-en-1-one.

ACS Pharmacol Transl Sci. 2024-10-14

[5]
TP53: the unluckiest of genes?

Cell Death Differ. 2025-2

[6]
Canonical and non-canonical functions of p53 isoforms: potentiating the complexity of tumor development and therapy resistance.

Cell Death Dis. 2024-6-12

[7]
Structural basis of p53 inactivation by cavity-creating cancer mutations and its implications for the development of mutant p53 reactivators.

Cell Death Dis. 2024-6-11

[8]
Elucidating the chain of command: our current understanding of critical target genes for p53-mediated tumor suppression.

Crit Rev Biochem Mol Biol. 2024

[9]
Targeting p53 misfolding conundrum by stabilizing agents and their analogs in breast cancer therapy: a comprehensive computational analysis.

Front Pharmacol. 2024-1-10

[10]
Exploring the Role of Globular Domain Locations on an Intrinsically Disordered Region of p53: A Molecular Dynamics Investigation.

J Chem Theory Comput. 2024-2-13

本文引用的文献

[1]
Gain of function of mutant p53 by coaggregation with multiple tumor suppressors.

Nat Chem Biol. 2011-3-27

[2]
Electron microscopy studies on the quaternary structure of p53 reveal different binding modes for p53 tetramers in complex with DNA.

Proc Natl Acad Sci U S A. 2010-12-22

[3]
Single-Molecule characterization of oligomerization kinetics and equilibria of the tumor suppressor p53.

Nucleic Acids Res. 2010-11-18

[4]
The tumor suppressor p53: from structures to drug discovery.

Cold Spring Harb Perspect Biol. 2010-2-10

[5]
Features and development of Coot.

Acta Crystallogr D Biol Crystallogr. 2010-4

[6]
Diversity in DNA recognition by p53 revealed by crystal structures with Hoogsteen base pairs.

Nat Struct Mol Biol. 2010-4-4

[7]
Structure of the p53 C-terminus bound to 14-3-3: implications for stabilization of the p53 tetramer.

FEBS Lett. 2010-3-3

[8]
Crystal structure of the p53 core domain bound to a full consensus site as a self-assembled tetramer.

Structure. 2010-2-10

[9]
Toward the rational design of p53-stabilizing drugs: probing the surface of the oncogenic Y220C mutant.

Chem Biol. 2010-1-29

[10]
Conservation of DNA-binding specificity and oligomerisation properties within the p53 family.

BMC Genomics. 2009-12-23

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索